FMC hikes excipient prices, blaming rising costs
FMC BioPolymer said today that effective 15 October, it will increase prices for its pharmaceutical and food brand products by 5 to 10 per cent on average, blaming increases in its own costs.
Archives for October 4, 2005
Healthcare facility cleared to make high-potency PET drug
A healthcare facility the US has been cleared by the Food and Drug Administration to manufacture high-strength fludeoxyglucose F 18, a drug used for diagnostic imaging with positron emission tomography (PET).
Biocatalyst deal pays off again for Codexis
Codexis has achieved a second technical milestone, earlier than expected, in a collaboration with Pfizer aimed at developing new biocatalysts for the manufacture of the number one drugmaker's products.
Sun Pharma sets out strategy for overseas plants
Sun Pharma of India has provided additional details of its plans for its new facility in Hungary, purchased in August and intended as a springboard to launch the company's ambitions in Europe and around the world, and its recently-acquired facility in...